+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Personalized Medicine In Oncology"

From
Genomics Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Genomics Market - Forecasts from 2025 to 2030

  • Report
  • August 2025
  • 154 Pages
  • Global
From
From
Oncology Drug Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Oncology Drug Market - Forecasts from 2025 to 2030

  • Report
  • June 2025
  • 141 Pages
  • Global
From
Soft Tissue Neoplasms Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Soft Tissue Neoplasms Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Gene Expression Market Report and Forecast 2025-2034 - Product Thumbnail Image

Gene Expression Market Report and Forecast 2025-2034

  • Report
  • July 2025
  • 350 Pages
  • Global
From
From
From
Genomics Market Report and Forecast 2025-2034 - Product Thumbnail Image

Genomics Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
From
From
From
From
From
From
From
From
Loading Indicator

Personalized Medicine in Oncology is a field of medicine that uses genomic information to tailor treatments to individual patients. This approach is based on the idea that each patient's cancer is unique and requires a personalized approach to treatment. Genomics is used to identify the genetic mutations that are driving the cancer, and then treatments are tailored to target those mutations. This approach has the potential to improve outcomes and reduce side effects, as treatments are more targeted and tailored to the individual patient. Companies in the Personalized Medicine in Oncology market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, and PerkinElmer. Show Less Read more